| 中文名 | (1R,2S)-1-叔丁氧羰基氨基-2-乙烯基环丙烷甲酸 |
|---|---|
| 英文名 | (1R,2S)-1-tert-Butoxycarbonylamino-2-vinylcyclopropanecarboxylic acid |
| 中文别名 |
丙肝药物中间体
(1R,2S)-1 - [ [(1,1-二甲基乙氧基)羰基]氨基] - 2-乙烯基-环丙烷甲酸 (1R,2S)-1-[(叔丁氧羰基)氨基]-2-乙烯基环丙烷甲酸*5 (1R,2S)-1-(叔丁氧基羰基氨基)-2-乙烯基环丙烷羧酸 阿拉匹韦中间体5 (1R,2S)-1-(BOC-氨基)-2-乙烯基环丙烷甲酸 阿那匹韦中间体V (1R,2S)-1-叔丁氧羰基氨基-烯基环丙烷甲酸 1-叔丁氧羰基氨基-2-乙烯基环丙烷甲酸 (1R,2S)-1-[(叔丁氧羰基)氨基]-2-乙烯基环丙烷甲酸 (1R,2S)-1-{[(叔-丁氧基)羰基]氨基}-2-乙烯基环丙烷-1-羧酸 |
| 英文别名 |
2-vinylcyclopropanecboxylic acid
(1R,2S)-1-tert-Butoxycbonylamino-2-vinylcyclopropanecboxylicaci (1R,2S)-1-((tert-butoxycbonyl)amino)-2-vinylcyclopropane-1-cboxylicacid (1R,2S)-2-ethenyl-1-[(2-methylpropan-2-yl)oxycarbonylamino]cyclopropane-1-carboxylic acid (1R,2S)-1-(tert-butoxycbonyl)-2-vinylcyclopropanecboxylic acid (1R,2S)-1-(Boc-amino)-2-vinylcyclopropanecboxylic Acid (1R,2S)-1-[(tert-butoxycarbonyl)amino]-2-ethenylcyclopropanecarboxylic acid (1R,2S)-1-({[(2-Methyl-2-propanyl)oxy]carbonyl}amino)-2-vinylcyclopropanecarboxylic acid (1R,2S)-N-tert-Butoxycbonyl-1-amino-2-vinylcyclopropanecboxylic acid (1R,2R)-1-((tert-butoxycbonyl)amino)-2-vinylcyclopropanecboxylic acid (1R,2S)-1-[(tert-Butoxycbonyl)amino]-2-vinylcyclopropanecboxylic Acid (1R,2S)-1-{[(tert-Butoxy)carbonyl]amino}-2-ethenylcyclopropane-1-cboxylic acid (1R,2S)-1-[(tert-Butoxycbonyl)amino]-2-ethenylcyclopropanecboxylic acid VINYL ACCA A.K.A (1R,2S) N-BOC-1-AMINO-2-VINYL CYC 1R,2S)-1-[(tert-Butoxycbonyl)amino]-2-vinylcyclopropanecboxylic acid VINYL ACCA EOS-61403 VINYL ACCA //BP Cyclopropanecboxylic acid, 1-[[(1,1-dimethylethoxy)carbonyl]amino]-2-ethenyl-, (1R,2S) 1-diMethylethoxy)carbonyl]amino]-2-ethenyl (1R,2S)-1-Boc-2-vinylcyclopropanecboxylic acid (1R,2S)-1-[[(1,1-diMethylethoxy)carbonyl]amino]-2-ethenyl-Cyclopropanecboxylic acid (1R,2S)-1-[(tert-butoxycarbonyl)amino]-2-vinylcyclopropanecarboxylic acid |
| 密度 | 1.2±0.1 g/cm3 |
|---|---|
| 沸点 | 361.0±42.0 °C at 760 mmHg |
| 分子式 | C11H17NO4 |
| 分子量 | 227.257 |
| 闪点 | 172.1±27.9 °C |
| 精确质量 | 227.115753 |
| PSA | 75.63000 |
| LogP | 1.33 |
| 外观性状 | 固体;White to Light yellow to Light orange powder to crystal |
| 蒸汽压 | 0.0±1.7 mmHg at 25°C |
| 折射率 | 1.508 |
| 储存条件 | 0-10°C;存放于惰性气体之中;避免空气,加热 |
| 危害码 (欧洲) | Xi |
|---|
|
~99%
159622-10-3 |
| 文献:Gilead Sciences, Inc. Patent: US2009/47252 A1, 2009 ; Location in patent: Page/Page column 33-34 ; |
|
~99%
159622-10-3 |
| 文献:IDENIX PHARMACEUTICALS, INC.; PARSY, Christophe Claude; ALEXANDRE, Francois-Rene; LEROY, Frederic; CONVARD, Thierry; SURLERAUX, Dominique Patent: WO2011/17389 A1, 2011 ; Location in patent: Page/Page column 130 ; WO 2011/017389 A1 |
|
~96%
159622-10-3 |
| 文献:REF PHARMA, LLC.; COATS, Steven, J. Patent: WO2013/106689 A1, 2013 ; Location in patent: Page/Page column 24 ; |
|
~71%
159622-10-3 |
| 文献:Kaneka Corporation Patent: EP2345633 A1, 2011 ; Location in patent: Page/Page column 12-13 ; |
|
~%
159622-10-3 |
| 文献:Synthetic Communications, , vol. 24, # 20 p. 2873 - 2876 |
|
~%
159622-10-3 |
| 文献:Synthetic Communications, , vol. 24, # 20 p. 2873 - 2876 |
|
~%
159622-10-3 |
| 文献:Synthetic Communications, , vol. 24, # 20 p. 2873 - 2876 |
|
~%
159622-10-3 |
| 文献:EP2345633 A1, ; |
| 上游产品 6 | |
|---|---|
| 下游产品 1 | |